ARCH Venture Partners

NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell

It’s been a question posed for years by many around the New York biotech scene: What is going on with the New York City Economic Development Corp.’s $150 million biotech fund, which was formed in 2013 but hadn’t made an investment?

Finally, today, there’s an answer. A small piece of the money from the NYCEDC’s NYC Life Sciences Fund is going to an ambitious new startup called HiberCell, which is focused on routing out the small numbers of dormant tumor cells that lurk in patients in remission and turn into deadly, recurring cancers.

“This definitely took time, I think we’ll acknowledge… Read more »





READ  UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy

Leave a Reply